Top Vaccines companies in Sweden by Net Cash Used For Investing Activities
Sweden
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 17.97 M
|
Dec. 31, 2023 | USD 0.16 | -4.29% |
|
Sweden |
|
| 2 |
USD 5.89 M
|
Dec. 31, 2023 | USD 2.43 | -5.44% |
|
Sweden |
|
| 3 |
USD 36.52 K
|
Dec. 31, 2023 | USD 1.26 | -1.32% |
|
Sweden |
|
| 4 |
USD 0.00
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
| 5 |
USD -8.09 K
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
| 6 |
USD -18.56 K
|
Dec. 31, 2023 | USD 1.25 | -0.41% |
|
Sweden |
|
| 7 |
USD -28.92 K
|
Dec. 31, 2023 | USD 1.30 | -5.64% |
|
Sweden |
|
| 8 |
USD -43.63 K
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
| 9 |
USD -72.05 K
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
| 10 |
USD -84.88 K
|
Dec. 31, 2023 | NA | NA |
|
Sweden |
|
| 11 |
USD -207.96 K
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
| 12 |
USD -409.21 K
|
Dec. 31, 2023 | USD 3.54 | -3.30% |
|
Sweden |
|
| 13 |
USD -1.26 M
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
| 14 |
USD -1.93 M
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
| 15 |
USD -2.26 M
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
| 16 |
USD -2.71 M
|
Aug. 31, 2024 | USD 1.49 | -4.08% |
|
Sweden |
|
| 17 |
USD -5.35 M
|
Dec. 31, 2023 | USD 31.05 | 0.32% |
|
Sweden |
|
| 18 |
USD -12.25 M
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
| 19 |
USD -14.26 M
|
Dec. 31, 2023 | USD 0.79 | -2.96% |
|
Sweden |
|
| 20 |
USD -50.09 M
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
| 21 |
USD -85.74 M
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
| 22 |
USD -2.16 B
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
Frequently Asked Questions
-
Which Vaccines company in Sweden has the highest Net Cash Used For Investing Activities ?
The Vaccines company in Sweden with the highest Net Cash Used For Investing Activities is Cantargia AB (publ) (Stockholm Stock Exchange: CANTA.ST) at USD 17.97 M.
-
Which Vaccines company in Sweden has the lowest Net Cash Used For Investing Activities ?
The Vaccines company in Sweden with the lowest Net Cash Used For Investing Activities is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD -2.16 B.
-
What are the top 10 Vaccines companies in Sweden by Net Cash Used For Investing Activities ?
The top 10 Vaccines companies in Sweden by Net Cash Used For Investing Activities are Cantargia AB (publ), BioInvent International AB (publ), SynAct Pharma AB, Pila Pharma AB (publ), NextCell Pharma AB, Lipum AB (publ), IRLAB Therapeutics AB (publ), Mendus AB (publ), Enzymatica AB (publ) and Bio-Works Technologies AB (publ).
-
What are the bottom 10 Vaccines companies in Sweden by Net Cash Used For Investing Activities ?
The bottom 10 Vaccines companies in Sweden by Net Cash Used For Investing Activities are Swedish Orphan Biovitrum AB (publ), Vimian Group AB (publ), BioArctic AB (publ), Vicore Pharma Holding AB (publ), Moberg Pharma AB (publ), Probi AB (publ), Diamyd Medical AB (publ), Iconovo AB (publ), Alzinova AB (publ) and Genovis AB (publ.).
